A morphine/heroin vaccine with new hapten design attenuates behavioral effects in rats

September 30, 2011

Conclusion:  These results suggest that immunization with a novel vaccine is an effective means of inducing a morphineâ€�specific antibody response that is able to attenuate the behavioral and psychoactive effects of heroin. (Source: Journal of Neurochemistry) MedWorm Sponsor Message: Are you angry about the sentencing of the medics in Bahrain? If so please get in […]

Read the full article →

What is Oxycontin Treatment : Opioid Addiction Treatment Help

September 30, 2011

Oxycontin Treatment Basic Facts  The need for oxycontin treatment in the United States is great. Oxycontin has been helpful in the fight again severe pain. While most people who use oxycontin for pain never have addictive problems, it is important to know some basic facts about oxycontin. The generic name for oxycontin is oxycodone hydrochloride […]

Read the full article →

Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

September 27, 2011

We describe a mechanism whereby chronic blockade of opiate receptors, in spite of only partial opiate agonist action, may ultimately block dopaminergic activity causing anti-reward and relapse potential. While the direct comparison is not as yet available, toxicity to buprenorphine can be found in the scientific literature. In considering our cautionary note in this commentary, […]

Read the full article →

Buprenorphine/naloxone/lorazepam interaction: First report of an interaction, leading to respiratory depression: case report

September 24, 2011

(Source: Reactions) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple of days, plus support MedWorm at the same time.

Read the full article →

Oxycontin Addiction : 10 Signs To Check

September 23, 2011

Oxycontin Addiction and Opioid Addiction: The Problem  Oxycontin Addiction and Opioid addiction is a big problem in America. Numbers from the National Institute on Drug Abuse indicate that there were seven  million abusers of Rx drugs in 2009. The frequency of patients overdosing on Rx narcotics (on purpose or by accident) has tripled since the […]

Read the full article →

Buprenorphine Treatment : What is It?

September 22, 2011

What Is Buprenorphine Treatment ?  Buprenorphine treatment is another opioid dependence treatment. It is similar to methadone maintenance treatment. The Brand name for this medication is Suboxone. Opioid dependent patients have a very hard time getting and staying off opioids such as oxycontin, heroin, vicodin, and other narcotics. For those who are able to stop […]

Read the full article →

Buprenorphine Tablets and Suboxone Film : Formulations Webinar

September 16, 2011

Buprenorphine Tablets and Suboxone Film : New Formulations Webinar Click Here to Go Straight To The Buprenorphine Tablets and Suboxone Film New Formulations Webinar The Physicians clinical support system has free webinars for doctors to help run a suboxone clinic . The webinars are archived on the American Psychiatric Association web site and can be […]

Read the full article →

CADTH Rapid Response Report: Clinical evidence for Suboxone® (buprenorphine/naloxone) for short-term detoxification

September 14, 2011

Source: Canadian Agency for Drugs and Technologies in Health (CADTH) Area: News This Rapid Response Report from the Canadian Agency for Drugs and Technologies in Health (CADTH) discusses the available evidence regarding the comparative clinical efficacy and safety of short term (<4 weeks) use of Suboxone® (buprenorphine/naloxone) compared with other opioid detoxification agents such as […]

Read the full article →

Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

September 5, 2011

The objective was to achieve consensus on the conclusions to be drawn from this work. It was agreed that buprenorphine clearly behaves as a full [mu]-opioid agonist for analgesia in clinical practice, with no ceiling effect, but that there is a ceiling effect for respiratory depression, reducing the likelihood of this potentially fatal adverse event. […]

Read the full article →

Office-Based Opioid Treatment Keeps Ex-Inmates Out of Jail

September 5, 2011

MINNEAPOLIS — Opioid-dependent patients with a history of incarceration do well with office-based buprenorphine/naloxone therapy and have fewer interactions over time with the legal and criminal justice systems, according to a data analysis of a previous randomized, controlled trial. (Source: Clinical Psychiatry News)

Read the full article →

← Previous Entries

Next Entries →